
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxNLUhSSUhucnNWZ0haQlA3Ty1vTDA0bEFEdVVyMEdvSFJWS3ZIUVE5V2o4bmtaWHR0NHVEY1lnZy1xQnNnRjMwcWhOaHJpcU5NTDRWNHA5SHJvbjdaNDdNZF92TTFfaUFLVHk1V2RacjdkMmp0UFdjTjd1MEtab1Nidi14VGNqLW9OYW9KLU54SXhFYXUwd2ZfN3Z5ZjdqeEttR3RwZjU1Q2dGQTJJd0NJWXJEcHBLQUlaWlhHSmFWNFhxSXpmSzk5VmZQX1ZreHdsc3FFeDR0SUZGUzREQWFxU19vR1RYeWp4N3R1THBTWTZtR0hnWmc?oc=5" target="_blank">Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>

